Are propafenone and propafenone hydrochloride the same medication?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 20, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Yes, propafenone and propafenone hydrochloride are the same medication

Propafenone and propafenone hydrochloride refer to the same antiarrhythmic drug—the "hydrochloride" simply denotes the salt form used in pharmaceutical formulations. This is a standard pharmaceutical convention where the active ingredient (propafenone) is combined with hydrochloric acid to create a stable, water-soluble salt (propafenone hydrochloride) suitable for oral administration 1, 2.

Key Points

  • Chemical identity: Propafenone hydrochloride is the pharmaceutical salt form of propafenone, used in all commercially available formulations 1, 2

  • Interchangeable terminology: In clinical practice, guidelines, and prescribing, the terms "propafenone" and "propafenone hydrochloride" are used interchangeably to refer to the same medication 3, 4, 5

  • Available formulations: Both immediate-release tablets (150,225,300 mg) and extended-release capsules (225,325,425 mg) contain propafenone hydrochloride as the active ingredient 1, 2

Clinical Implications

When you see either term in:

  • Guidelines: They reference the same drug with identical dosing, indications, and contraindications 3, 5
  • Prescriptions: Both names refer to the same medication
  • Research literature: Studies use both terms interchangeably 6, 7, 8

The hydrochloride designation is simply the chemical specification of the salt form—it does not represent a different drug, different potency, or different clinical entity. All dosing recommendations (e.g., 150-300 mg three times daily for immediate release, or 225-425 mg twice daily for extended release) apply to propafenone hydrochloride 3, 5.

References

Research

Clinical pharmacokinetics of propafenone.

Clinical pharmacokinetics, 1991

Research

[Propafenone--a promising anti-arrhythmia agent?].

Sbornik vedeckych praci Lekarske fakulty Karlovy univerzity v Hradci Kralove. Supplementum, 1990

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.